Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Trial of a Digital Therapeutic for Smoking Cessation Among Persons Living With HIV

NCT06883097 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT06883097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06883097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Trial of a Digital Therapeutic for Smoking Cessation Among Persons Living With HIV
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Recruiting
Start date
August 18, 2025
Completion date
September 30, 2028
Enrollment
314 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer prevention, human immunodeficiency virus (hiv), smoking cessation, smoking cessation; tobacco dependence, tobacco, tobacco abstinence, tobacco dependence caused by cigarettes